Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 074031
Company: NORVIUM BIOSCIENCE
Company: NORVIUM BIOSCIENCE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TRIAZOLAM | TRIAZOLAM | 0.125MG | TABLET;ORAL | Discontinued | None | No | No |
TRIAZOLAM | TRIAZOLAM | 0.25MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/25/1994 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
09/18/2008 | SUPPL-5 | Labeling |
Label is not available on this site. |
||
03/18/2004 | SUPPL-4 | Labeling |
Label is not available on this site. |
||
03/27/1997 | SUPPL-2 | Labeling |
Label is not available on this site. |
||
07/06/1994 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |